Skip to main content
logo
Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
80.20
-0.80 (-0.99%)
Aug 4, 2026, 3:56 PM CET

Oncoinvent ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
28.0728.078.10.356.280.77
Revenue Growth
4021.73%246.40%2188.98%-94.37%711.76%28.79%
Gross Profit
28.0728.078.10.356.280.77
Operating Income
-158.33-158.33-141.02-191.82-110.61-314.46
Net Income
-155.07-155.07-140.2-190.4-106.28-309.36
Earnings Per Share
-1.25-1.25-5.61-13.00-548.00-352.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
177.6177.6133.6730.1196.02436.65
Total Debt
3.553.557.4512.1712.030.94
Net Cash (Debt)
174.05174.05126.2217.92183.99435.7
Net Cash Growth
151.63%37.90%604.25%-90.26%-57.77%-39.51%
Net Cash Per Share
1.401.405.051.25209.18495.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-129.87-129.87-87.94-225.1-89.19-303.34
Capital Expenditures
-0.12-0.12-1.8--3.98-
Free Cash Flow
-129.99-129.99-89.75-225.1-93.17-303.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-564.07%-564.07%-1740.32%-54186.20%-1760.48%-40628.40%
Pretax Margin
-367.26%-537.84%-1711.14%-53785.59%-1691.55%-39969.51%
Profit Margin
-367.26%-537.84%-1711.14%-53785.60%-1691.55%-39969.50%
FCF Margin
-463.11%-463.11%-1107.55%-63587.90%-1482.94%-39191.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.927.8359.689.7912.761279.30